VKTX icon

Viking Therapeutics

140 hedge funds and large institutions have $230M invested in Viking Therapeutics in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 49 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less ownership

Funds ownership:

21% less capital invested

Capital invested by funds: $290M → $230M (-$60M)

31% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 49

Holders
140
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8.28M
Puts
$2.76M
Net Calls
Net Calls Change

Top Buyers

1 +$4.55M
2 +$2.03M
3 +$1.47M
4
SG Americas Securities
SG Americas Securities
New York
+$1.36M
5
Morgan Stanley
Morgan Stanley
New York
+$1.01M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$540K
52
$499K
53
$474K
54
$449K
55
$430K
56
$426K
57
$422K
58
$420K
59
$376K
60
$357K
61
$345K
62
$281K
63
$272K
64
$271K
65
$261K
66
$247K
67
$232K
68
$228K
69
$216K
70
$207K
71
$196K
72
$186K
73
$166K
74
$165K
75
$153K